2016
DOI: 10.1016/j.pbiomolbio.2016.01.003
|View full text |Cite
|
Sign up to set email alerts
|

The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblasts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0
3

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(43 citation statements)
references
References 55 publications
1
39
0
3
Order By: Relevance
“…CA has been shown to stimulate myometrial oxytocin receptor expression and to induce preterm labour when infused into sheep . Furthermore, addition of CA to the culture medium of rodent and human in vitro models of the fetal heart resulted in arrhythmia, suggesting that this BA causes potentially fatal fetal arrhythmia . Therefore, the finding of an association between severe ICP (with maternal serum BA ≥40 micromol/l) and fetal complications has influenced clinical practice and increased the focus on monitoring of BA concentrations .…”
Section: Discussionmentioning
confidence: 99%
“…CA has been shown to stimulate myometrial oxytocin receptor expression and to induce preterm labour when infused into sheep . Furthermore, addition of CA to the culture medium of rodent and human in vitro models of the fetal heart resulted in arrhythmia, suggesting that this BA causes potentially fatal fetal arrhythmia . Therefore, the finding of an association between severe ICP (with maternal serum BA ≥40 micromol/l) and fetal complications has influenced clinical practice and increased the focus on monitoring of BA concentrations .…”
Section: Discussionmentioning
confidence: 99%
“…Isolation of neonatal rat ventricular cardiomyocytes and myofibroblasts from 1-2-d-old Sprague-Dawley rats was done in accordance with the guidelines of the Home Office Animal (Scientific Procedures) Act of 1986 of the United Kingdom. Cardiomyocytes and myofibroblasts were isolated and cultured as previously described (31). Monocultures of cardiomyocytes or myofibroblasts were seeded into MatTek dishes (13 cm 2 ; MatTek, Ashland, MA, USA) or plastic-bottom dishes (35 mm, CytoOne; USA Scientific, Ocala, FL, USA).…”
Section: Neonatal Rat Cells Used For Contact Motility Studiesmentioning
confidence: 99%
“…For the coculture experiments, cardiomyocytes were also plated in dishes, with myofibroblasts seeded on top on the subsequent day. The myofibroblasts were detached as previously described (31), spun, and resuspended in 1 ml HBSS per 1 million cells. The myofibroblasts were then labeled by incubating for 20 min at 37°C and 1% CO 2 with either Vybrant DiI (excitation/emission: 549/565 nm; Thermo Fisher Scientific, Waltham, MA, USA) or WGA-488 (wheat germ agglutinin-488, excitation/emission: 495/519 nm; Thermo Fisher Scientific) for recognition afterward.…”
Section: Neonatal Rat Cells Used For Contact Motility Studiesmentioning
confidence: 99%
“…Their initial report revealed that taurocholate altered calcium dynamics which led to loss of synchronous beating of cardiomyocytes. The same group showed that taurocholic acid was responsible for reduced contractility and pacemaker activity while ursodeoxycholic acid protected against reentrant arrhythmias by modulating potassium conductance …”
Section: Bile Acids and Cardiovascular Functionmentioning
confidence: 99%
“…The same group showed that taurocholic acid was responsible for reduced contractility and pacemaker activity 61 while ursodeoxycholic acid protected against reentrant arrhythmias by modulating potassium conductance. 62,63 Due to the difficulties of conducting studies in the setting of ICP, such conclusions are mainly based on cell-cultures and animal models with few studies looking into the arrhythmogenic effects of BA in humans. 64 Rainer et al 65 showed that taurocholic acid-induced concentration-dependent arrhythmia in human atrial myocardium and noted an association between atrial fibrillation and higher serum levels of nonursodeoxycholic bile acid conjugates and low levels of ursodeoxycholic acid conjugates in 250 patients.…”
Section: Cardiac Effectsmentioning
confidence: 99%